{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T12:16:18Z","timestamp":1789128978981,"version":"build-2803163510"},"reference-count":49,"publisher":"Oxford University Press (OUP)","issue":"4","license":[{"start":{"date-parts":[[2025,7,16]],"date-time":"2025-07-16T00:00:00Z","timestamp":1752624000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,10,15]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Background<\/jats:title>\n                  <jats:p>The gut microbiota has been implicated in driving coronavirus disease 2019 (COVID-19) disease severity, but the underlying mechanisms remain unknown. We investigated the relationship between the gut microbiota and development of symptomatic COVID-19 in children.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>We prospectively collected stool and plasma samples from 229 children who were exposed to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), including 45 COVID-19 negative, 57 with asymptomatic COVID-19, and 127 with symptomatic COVID-19. We performed shotgun metagenomic sequencing on the stool samples to characterize the microbial taxa and functional profiles. Plasma cytokine levels were measured in SARS-CoV-2\u2013infected individuals.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>Children with symptomatic COVID-19 had reduced microbial biodiversity and decreased functional capacity for several metabolic pathways, including a reduction in the tyrosine biosynthesis pathway, as compared to SARS-CoV-2\u2013uninfected children or those with asymptomatic infection. The abundance of the tyrosine biosynthesis pathway was associated with plasma levels of interferon alpha (IFN-\u03b1), which were lower in children with symptomatic COVID-19.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>Our findings highlight a relationship between the ability of the gut microbiota to metabolize tyrosine and the development of COVID-19 symptoms in children. More generally, our study suggests that the gut microbiota may help protect against more severe forms of COVID-19, potentially by modulating IFN-\u03b1.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/infdis\/jiaf325","type":"journal-article","created":{"date-parts":[[2025,6,13]],"date-time":"2025-06-13T07:45:31Z","timestamp":1749800731000},"page":"796-805","source":"Crossref","is-referenced-by-count":1,"title":["Decreased Microbiota-Driven Tyrosine Metabolism Is Associated With Symptomatic COVID-19 in Children"],"prefix":"10.1093","volume":"232","author":[{"given":"Danting","family":"Jiang","sequence":"first","affiliation":[{"name":"Division of Infectious Diseases, Department of Pediatrics, Duke University School of Medicine , Durham, North Carolina ,","place":["USA"]},{"name":"Program in Computational Biology and Bioinformatics, Duke University , Durham, North Carolina ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jillian H","family":"Hurst","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases, Department of Pediatrics, Duke University School of Medicine , Durham, North Carolina ,","place":["USA"]},{"name":"Duke Microbiome Center, Duke University School of Medicine , Durham, North Carolina ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ghada","family":"Mohamed","sequence":"additional","affiliation":[{"name":"Duke Microbiome Center, Duke University School of Medicine , Durham, North Carolina ,","place":["USA"]},{"name":"Division of Gastroenterology, Department of Medicine, Duke University School of Medicine , Durham, North Carolina ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8819-2315","authenticated-orcid":false,"given":"Matthew S","family":"Kelly","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases, Department of Pediatrics, Duke University School of Medicine , Durham, North Carolina ,","place":["USA"]},{"name":"Duke Microbiome Center, Duke University School of Medicine , Durham, North Carolina ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jatin","family":"Roper","sequence":"additional","affiliation":[{"name":"Duke Microbiome Center, Duke University School of Medicine , Durham, North Carolina ,","place":["USA"]},{"name":"Division of Gastroenterology, Department of Medicine, Duke University School of Medicine , Durham, North Carolina ,","place":["USA"]},{"name":"Department of Pharmacology and Cancer Biology, Department of Medicine, Duke University School of Medicine , Durham, North Carolina ,","place":["USA"]},{"name":"Department of Cell Biology, Department of Medicine, Duke University School of Medicine , Durham, North Carolina ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9544-2551","authenticated-orcid":false,"given":"Neeraj K","family":"Surana","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases, Department of Pediatrics, Duke University School of Medicine , Durham, North Carolina ,","place":["USA"]},{"name":"Duke Microbiome Center, Duke University School of Medicine , Durham, North Carolina ,","place":["USA"]},{"name":"Department of Cell Biology, Department of Medicine, Duke University School of Medicine , Durham, North Carolina ,","place":["USA"]},{"name":"Department of Molecular Genetics and Microbiology, Duke University School of Medicine , Durham, North Carolina ,","place":["USA"]},{"name":"Department of Integrative Immunobiology, Duke University School of Medicine , Durham, North Carolina ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2025,7,16]]},"reference":[{"key":"2025101515152195700_jiaf325-B1","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1001\/jama.2020.12839","article-title":"Pathophysiology, transmission, diagnosis, and treatment of coronavirus disease 2019 (COVID-19): a review","volume":"324","author":"Wiersinga","year":"2020","journal-title":"JAMA"},{"key":"2025101515152195700_jiaf325-B2","doi-asserted-by":"crossref","first-page":"m1985","DOI":"10.1136\/bmj.m1985","article-title":"Features of 20 133 UK patients in hospital with Covid-19 using the ISARIC WHO clinical characterisation protocol: prospective observational cohort study","volume":"369","author":"Docherty","year":"2020","journal-title":"BMJ"},{"key":"2025101515152195700_jiaf325-B3","doi-asserted-by":"crossref","first-page":"e13128","DOI":"10.1111\/obr.13128","article-title":"Individuals with obesity and COVID-19: a global perspective on the epidemiology and biological relationships","volume":"21","author":"Popkin","year":"2020","journal-title":"Obes Rev"},{"key":"2025101515152195700_jiaf325-B4","author":"Centers for Disease Control and Prevention"},{"key":"2025101515152195700_jiaf325-B5","doi-asserted-by":"crossref","first-page":"1708","DOI":"10.1056\/NEJMoa2002032","article-title":"Clinical characteristics of coronavirus disease 2019 in China","volume":"382","author":"Guan","year":"2020","journal-title":"N Engl J Med"},{"key":"2025101515152195700_jiaf325-B6","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1056\/NEJMc2005073","article-title":"SARS-CoV-2 infection in children","volume":"382","author":"Lu","year":"2020","journal-title":"N Engl J Med"},{"key":"2025101515152195700_jiaf325-B7","doi-asserted-by":"crossref","first-page":"422","DOI":"10.15585\/mmwr.mm6914e4","article-title":"Coronavirus disease 2019 in children\u2014United States, February 12\u2013April 2, 2020","volume":"69","author":"CDC COVID-19 Response Team","year":"2020","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"2025101515152195700_jiaf325-B8","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1038\/s41591-020-0962-9","article-title":"Age-dependent effects in the transmission and control of COVID-19 epidemics","volume":"26","author":"Davies","year":"2020","journal-title":"Nat Med"},{"key":"2025101515152195700_jiaf325-B9","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1038\/s41591-020-01202-8","article-title":"Immune determinants of COVID-19 disease presentation and severity","volume":"27","author":"Brodin","year":"2021","journal-title":"Nat Med"},{"key":"2025101515152195700_jiaf325-B10","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1126\/science.abc1669","article-title":"SARS-CoV-2 productively infects human gut enterocytes","volume":"369","author":"Lamers","year":"2020","journal-title":"Science"},{"key":"2025101515152195700_jiaf325-B11","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1093\/cid\/ciaa925","article-title":"Direct evidence of active SARS-CoV-2 replication in the intestine","volume":"73","author":"Qian","year":"2021","journal-title":"Clin Infect Dis"},{"key":"2025101515152195700_jiaf325-B12","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1038\/s41591-020-0817-4","article-title":"Characteristics of pediatric SARS-CoV-2 infection and potential evidence for persistent fecal viral shedding","volume":"26","author":"Xu","year":"2020","journal-title":"Nat Med"},{"key":"2025101515152195700_jiaf325-B13","doi-asserted-by":"crossref","first-page":"10.1126\/science.aad5872","DOI":"10.1126\/science.aad5872","article-title":"Viral immunity. Transkingdom control of viral infection and immunity in the mammalian intestine","volume":"351","author":"Pfeiffer","year":"2016","journal-title":"Science"},{"key":"2025101515152195700_jiaf325-B14","first-page":"4197","article-title":"Deciphering the tete-a-tete between the microbiota and the immune system","volume":"124","author":"Surana","year":"2014","journal-title":"J Clin Invest"},{"key":"2025101515152195700_jiaf325-B15","doi-asserted-by":"crossref","first-page":"1710","DOI":"10.4049\/jimmunol.2100215","article-title":"A modern-world view of host-microbiota-pathogen interactions","volume":"207","author":"Tan","year":"2021","journal-title":"J Immunol"},{"key":"2025101515152195700_jiaf325-B16","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1038\/s41392-022-00986-0","article-title":"Alterations in microbiota of patients with COVID-19: potential mechanisms and therapeutic interventions","volume":"7","author":"Wang","year":"2022","journal-title":"Signal Transduct Target Ther"},{"key":"2025101515152195700_jiaf325-B17","doi-asserted-by":"crossref","first-page":"5926","DOI":"10.1038\/s41467-022-33395-6","article-title":"Gut microbiome dysbiosis in antibiotic-treated COVID-19 patients is associated with microbial translocation and bacteremia","volume":"13","author":"Bernard-Raichon","year":"2022","journal-title":"Nat Commun"},{"key":"2025101515152195700_jiaf325-B18","doi-asserted-by":"crossref","first-page":"1211348","DOI":"10.3389\/fcimb.2023.1211348","article-title":"COVID-19 alters human microbiomes: a meta-analysis","volume":"13","author":"Reuben","year":"2023","journal-title":"Front Cell Infect Microbiol"},{"key":"2025101515152195700_jiaf325-B19","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1186\/s13073-023-01202-6","article-title":"Metagenomic assessment of gut microbial communities and risk of severe COVID-19","volume":"15","author":"Nguyen","year":"2023","journal-title":"Genome Med"},{"key":"2025101515152195700_jiaf325-B20","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1136\/gutjnl-2020-323020","article-title":"Gut microbiota composition reflects disease severity and dysfunctional immune responses in patients with COVID-19","volume":"70","author":"Yeoh","year":"2021","journal-title":"Gut"},{"key":"2025101515152195700_jiaf325-B21","doi-asserted-by":"crossref","first-page":"2371","DOI":"10.1136\/gutjnl-2021-326599","article-title":"Gut microbiota changes are detected in asymptomatic very young children with SARS-CoV-2 infection","volume":"71","author":"Nashed","year":"2022","journal-title":"Gut"},{"key":"2025101515152195700_jiaf325-B22","doi-asserted-by":"crossref","first-page":"908492","DOI":"10.3389\/fcimb.2022.908492","article-title":"The relationship between pediatric gut microbiota and SARS-CoV-2 infection","volume":"12","author":"Romani","year":"2022","journal-title":"Front Cell Infect Microbiol"},{"key":"2025101515152195700_jiaf325-B23","doi-asserted-by":"crossref","first-page":"3175","DOI":"10.1007\/s00431-022-04494-9","article-title":"Intestinal microbiota composition of children with infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and multisystem inflammatory syndrome (MIS-C)","volume":"181","author":"Suskun","year":"2022","journal-title":"Eur J Pediatr"},{"key":"2025101515152195700_jiaf325-B24","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1016\/j.jgg.2021.05.004","article-title":"Progressive deterioration of the upper respiratory tract and the gut microbiomes in children during the early infection stages of COVID-19","volume":"48","author":"Xu","year":"2021","journal-title":"J Genet Genomics"},{"key":"2025101515152195700_jiaf325-B25","doi-asserted-by":"crossref","first-page":"e2875","DOI":"10.1093\/cid\/ciaa1693","article-title":"Severe acute respiratory syndrome coronavirus 2 infections among children in the Biospecimens from Respiratory Virus\u2013Exposed Kids (BRAVE Kids) study","volume":"73","author":"Hurst","year":"2021","journal-title":"Clin Infect Dis"},{"key":"2025101515152195700_jiaf325-B26","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.1038\/s41587-023-01688-w","article-title":"Extending and improving metagenomic taxonomic profiling with uncharacterized species using MetaPhlAn 4","volume":"41","author":"Blanco-M\u00edguez","year":"2023","journal-title":"Nat Biotechnol"},{"key":"2025101515152195700_jiaf325-B27","doi-asserted-by":"crossref","first-page":"e65088","DOI":"10.7554\/eLife.65088","article-title":"Integrating taxonomic, functional, and strain-level profiling of diverse microbial communities with bioBakery 3","volume":"10","author":"Beghini","year":"2021","journal-title":"eLife"},{"key":"2025101515152195700_jiaf325-B28","doi-asserted-by":"crossref","first-page":"e1009442","DOI":"10.1371\/journal.pcbi.1009442","article-title":"Multivariable association discovery in population-scale meta-omics studies","volume":"17","author":"Mallick","year":"2021","journal-title":"PLoS Comput Biol"},{"key":"2025101515152195700_jiaf325-B29","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1111\/1467-9868.00293","article-title":"Estimating the number of clusters in a data set via the gap statistic","volume":"63","author":"Tibshirani","year":"2001","journal-title":"J R Stat"},{"key":"2025101515152195700_jiaf325-B30","first-page":"32","article-title":"A new method for non-parametric multivariate analysis of variance","volume":"26","author":"Anderson","year":"2001","journal-title":"Austral Ecol"},{"key":"2025101515152195700_jiaf325-B31","author":"Oksanen","year":"2025"},{"key":"2025101515152195700_jiaf325-B32","volume-title":"An R companion to applied regression","author":"Fox","year":"2019","edition":"3rd ed"},{"key":"2025101515152195700_jiaf325-B33","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1002\/bimj.200810425","article-title":"Simultaneous inference in general parametric models","volume":"50","author":"Hothorn","year":"2008","journal-title":"Biom J"},{"key":"2025101515152195700_jiaf325-B34","doi-asserted-by":"crossref","DOI":"10.4135\/9781412983433","volume-title":"Applied logistic regression analysis","author":"Menard","year":"2002"},{"key":"2025101515152195700_jiaf325-B35","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1038\/s41564-018-0278-4","article-title":"The role of the microbiota in infectious diseases","volume":"4","author":"Libertucci","year":"2019","journal-title":"Nat Microbiol"},{"key":"2025101515152195700_jiaf325-B36","doi-asserted-by":"crossref","first-page":"e692","DOI":"10.1016\/S2666-5247(23)00171-4","article-title":"Dynamics of inflammatory responses after SARS-CoV-2 infection by vaccination status in the USA: a prospective cohort study","volume":"4","author":"Zhu","year":"2023","journal-title":"Lancet Microbe"},{"key":"2025101515152195700_jiaf325-B37","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1093\/infdis\/jiaa363","article-title":"Serum cytokine and chemokine profile in relation to the severity of coronavirus disease 2019 in China","volume":"222","author":"Chi","year":"2020","journal-title":"J Infect Dis"},{"key":"2025101515152195700_jiaf325-B38","doi-asserted-by":"crossref","first-page":"e0247041","DOI":"10.1371\/journal.pone.0247041","article-title":"16S rRNA gene sequencing of rectal swab in patients affected by COVID-19","volume":"16","author":"Mazzarelli","year":"2021","journal-title":"PLoS One"},{"key":"2025101515152195700_jiaf325-B39","doi-asserted-by":"crossref","first-page":"e000871","DOI":"10.1136\/bmjgast-2022-000871","article-title":"Lost microbes of COVID-19: Bifidobacterium, Faecalibacterium depletion and decreased microbiome diversity associated with SARS-CoV-2 infection severity","volume":"9","author":"Hazan","year":"2022","journal-title":"BMJ Open Gastroenterol"},{"key":"2025101515152195700_jiaf325-B40","doi-asserted-by":"crossref","first-page":"5235","DOI":"10.1038\/s41467-022-32991-w","article-title":"Dissecting the role of the human microbiome in COVID-19 via metagenome-assembled genomes","volume":"13","author":"Ke","year":"2022","journal-title":"Nat Commun"},{"key":"2025101515152195700_jiaf325-B41","doi-asserted-by":"crossref","first-page":"3884","DOI":"10.1016\/j.cell.2021.05.030","article-title":"Bifidobacteria-mediated immune system imprinting early in life","volume":"184","author":"Henrick","year":"2021","journal-title":"Cell"},{"key":"2025101515152195700_jiaf325-B42","doi-asserted-by":"crossref","first-page":"747816","DOI":"10.3389\/fcimb.2021.747816","article-title":"A pro-inflammatory gut microbiome characterizes SARS-CoV-2 infected patients and a reduction in the connectivity of an anti-inflammatory bacterial network associates with severe COVID-19","volume":"11","author":"Reinold","year":"2021","journal-title":"Front Cell Infect Microbiol"},{"key":"2025101515152195700_jiaf325-B43","doi-asserted-by":"crossref","first-page":"2073131","DOI":"10.1080\/19490976.2022.2073131","article-title":"A high-risk gut microbiota configuration associates with fatal hyperinflammatory immune and metabolic responses to SARS-CoV-2","volume":"14","author":"Albrich","year":"2022","journal-title":"Gut Microbes"},{"key":"2025101515152195700_jiaf325-B44","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1126\/science.abc6261","article-title":"Systems biological assessment of immunity to mild versus severe COVID-19 infection in humans","volume":"369","author":"Arunachalam","year":"2020","journal-title":"Science"},{"key":"2025101515152195700_jiaf325-B45","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1016\/j.cell.2020.04.026","article-title":"Imbalanced host response to SARS-CoV-2 drives development of COVID-19","volume":"181","author":"Blanco-Melo","year":"2020","journal-title":"Cell"},{"key":"2025101515152195700_jiaf325-B46","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1056\/NEJMoa020047","article-title":"Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection","volume":"347","author":"Fried","year":"2002","journal-title":"N Engl J Med"},{"key":"2025101515152195700_jiaf325-B47","doi-asserted-by":"crossref","first-page":"1069894","DOI":"10.3389\/fimmu.2023.1069894","article-title":"Efficacy of interferon alpha for the treatment of hospitalized patients with COVID-19: a meta-analysis","volume":"14","author":"Buchynskyi","year":"2023","journal-title":"Front Immunol"},{"key":"2025101515152195700_jiaf325-B48","doi-asserted-by":"crossref","first-page":"6615","DOI":"10.1038\/s41467-022-34260-2","article-title":"Immunomodulatory fecal metabolites are associated with mortality in COVID-19 patients with respiratory failure","volume":"13","author":"Stutz","year":"2022","journal-title":"Nat Commun"},{"key":"2025101515152195700_jiaf325-B49","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1126\/science.aam5336","article-title":"The microbial metabolite desaminotyrosine protects from influenza through type I interferon","volume":"357","author":"Steed","year":"2017","journal-title":"Science"}],"container-title":["The Journal of Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jid\/advance-article-pdf\/doi\/10.1093\/infdis\/jiaf325\/63717086\/jiaf325.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jid\/article-pdf\/232\/4\/796\/63717086\/jiaf325.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jid\/article-pdf\/232\/4\/796\/63717086\/jiaf325.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T19:17:47Z","timestamp":1760555867000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jid\/article\/232\/4\/796\/8196088"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,16]]},"references-count":49,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2025,7,16]]},"published-print":{"date-parts":[[2025,10,15]]}},"URL":"https:\/\/doi.org\/10.1093\/infdis\/jiaf325","relation":{},"ISSN":["0022-1899","1537-6613"],"issn-type":[{"value":"0022-1899","type":"print"},{"value":"1537-6613","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025,10,15]]},"published":{"date-parts":[[2025,7,16]]}}}